Clinical Trial Update: Exercise Intolerance in Heart Failure

View source ↗

Summary

A clinical trial from Johns Hopkins is evaluating exercise intolerance in heart failure with preserved ejection fraction (HFpEF) and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction

Snippet

Sponsor: Johns Hopkins University | Conditions: Heart Failure With Normal Ejection Fraction | Status: RECRUITING